Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 25 February 2014 | By Alexander Gaffney, RAC,
US pharmaceutical regulators in the US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) are looking to hire a new executive to head up its Office of Regulatory Policy (ORP).
The announcement, made in a 24 February 2014 posting on the USA Jobs website, calls for someone with legal training and at least five years of "specialized experience providing legal advice" on the development, interpretation or implementation of regulations, laws and policies.
The office is currently led by Acting Director Nancy Hayes and Deputy Director Carol Bennett, according to FDA's website.
CDER's listing notes that ORP is highly influential in crafting policies impacting a wide range of areas, including drug safety, clinical trials, new drug applications, over-the-counter medications, drug quality, good manufacturing practices, drug promotion and marketing, and more.
Applicants have until 24 March 2014 to submit their resumes for the position.
ORP Director Posting
Tags: Office of Regulatory Policy, ORP, Latest News